INVESTMENT IN DISRUPTIVE EXPONENTIAL TECHNOLOGIES



Similar documents
Future Smart Cities. Dr. James Canton CEO & Chairman GlobalFuturist.com

Toward Acceleration of Open Innovation

Oracle Buys MICROS Systems Adds Innovative Hospitality and Retail Technology Vendor to Expand Oracle into More Industries

Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences

Big Data Trends A Basis for Personalized Medicine

A new era for the Life Sciences industry

How Big Data Is Hoping To Power Predictive Analytics

Procurement Outsourcing and. Shared Service Centers. SANFORD INTERNATIONAL I Global Sourcing I Supply Chain I Procurement I.

The Data Lifecycle: Managing Data through Business. Ewan Willars Friday 27 February

Smart Manufacturing as a Real-Time Networked Enterprise and a Market-Driven Innovation Platform

It s a New World: Innovations in Oncology Data Analytics. By Mahmood Majeed and Prashant Poddar

Profile. Business solutions with a difference

1. What are the key strengths and weaknesses of the UK s innovation system in relation to business-university collaboration?

Quality by Design Concept

SAN DIEGO S CLEANTECH INDUSTRY AT A GLANCE

Recruitment forecasting. Employer branding. Sourcing strategies. Selection processes. Assessment methodologies. On boarding of new hires

EXECUTIVE SUMMARY Prepared for: Pharmaceutical Research and Manufacturers of America (PhRMA) Prepared by: Battelle Technology Partnership Practice

World s Largest Healthcare Services Platform

Stephen Worn Global CTO & Board Director DatacenterDynamics

THE NEXT FRONTIER IN COMPUTING QUANTUM OPTICAL COMPUTING. Presentation For Venture Capital Investment

Manjula Ambur NASA Langley Research Center April 2014

Digital Insurance Era: Stretch Your Boundaries

Market Research and Competitive Intelligence Priorities

Intermediate Advanced All

SAP Solution Brief SAP HANA. Transform Your Future with Better Business Insight Using Predictive Analytics

Career Academy Overview Parent and Community Meeting

Dr Alexander Henzing

International Conference On Factoring And Other Receivables Finance Products

The Canadian perspective Retail landscape transformation. The way that Canadians live, work and shop is about to change profoundly

Social Media Implementations

Sustainable Innovation for Sustainable Life

Big Data An Opportunity or a Distraction? Signal or Noise?

How does Big Data disrupt the technology ecosystem of the public cloud?

Automating Cell Biology Annual general meeting, September 7, Phase Holographic Imaging

How To Change Medicine

Johan Hallberg Research Manager / Industry Analyst IDC Nordic Services & Sourcing Digital Transformation Global CIO Agenda

The Commercialization of Technology Concepts into Medical Products

The Aerospace & Defence industry of tomorrow

Highlights of the 2015 CEO Survey: Business Leaders Are Betting on Tech

From Data to Foresight:

Hitachi Announces to Establish Hitachi Global Center for Innovative Analytics to Accelerate Global Expansion of Big Data-Related Businesses

Head of CIO Office Information Services

Healthcare Challenges and Trends The Patient at the Heart of Care

How to Develop Successful Enterprise Risk and Vendor Management Programs

CONNECTING DATA WITH BUSINESS

Building for the future

WHITE PAPER. Leveraging Open HMI Technologies for Convergence & the IIoT Boom. IIoT M2M. Industry 4.0. Big Data. IoT

SIPBS Portfolio Entry

Aon Risk Solutions. Life Sciences Practice. Providing End-to-End Solutions for Life Sciences Companies. Risk. Reinsurance. Human Resources.

Proposal for the Theme on Big Data. Analytics. Qiang Yang, HKUST Jiannong Cao, PolyU Qi-man Shao, CUHK. May 2015

BIOVIA: SCIENTIFIC INNOVATION IN THE AGE OF EXPERIENCE A NEW SCIENTIFIC COLLABORATIVE ENVIRONMENT

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements

Ignite Ideas Accelerator Program Expression of Interest

GfK 2016 Tech Trends 2016

Going Global With Social Media Analytics

Marubeni & Biotech Business

UK- India Science Bridge: BioPharm 2020

Master of Science in Biomedical Sciences

The butterfly effect. How smart technology is set to completely transform utilities

BI STRATEGY FRAMEWORK

Healthcare Technology Trends

The Healthcare market in Brazil

Novartis extends commitment to help achieve final elimination of leprosy

KNOWLEDGENT WHITE PAPER. Big Data Enabling Better Pharmacovigilance

Tsugio Yamamoto. Financial Institutions Business Unit / Government & Public Corporation Business Unit Business Strategy

HOW IS C360 DIFFERENT THAN TRADITIONAL LEAD SCORING?

ANTI-AGING REGENERATIVE THE GLOBAL SERIES OF & AESTHETIC MEDICINE CONFERENCES & EXHIBITIONS

The Massachusetts Open Cloud (MOC)

Bringing Strategy to Life Using an Intelligent Data Platform to Become Data Ready. Informatica Government Summit April 23, 2015

GYAN VIHAR SCHOOL OF ENGINEERING & TECHNOLOGY M. TECH. CSE (2 YEARS PROGRAM)

2015 Digital & ecommerce Forum

Investor Growth Capital Stephen Campe

THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS

SHAPE YOUR FUTURE Your secret to getting and staying in shape. 1

A Guide to Open Source Transformation Services. How and Why Organizations are Making the Move to Open Source

Key Findings Advanced, Predictive Analytics Breaking the Barriers to Adoption

Artificial Intelligence and Testing. Kishore Durg AccentureTechnology June 2016

Transcription:

INVESTMENT IN DISRUPTIVE EXPONENTIAL TECHNOLOGIES

Deep Knowledge Ventures Deep Knowledge Ventures is a Hong Kong investment fund focusing on biotechnology, regenerative medicine, drug discovery, Artificial Intelligence, BigData analytical systems, bioinformatics and personalized medicine. Our principles: WE RE INTERESTED IN GIVING BIRTH TO INDUSTRIES AND NICHES THAT DON T EVEN EXIST YET, AND CREATING NEW COMPANIES IN THESE INDUS- TRIES WHERE THERE ARE NO COMPETITORS OUR PORTFOLIO COMPANIES EXIST IN A NON-COMPETITIVE ENVIRONMENT WE ANALYZE AREAS IN WHICH WE ANTICIPATE BOOMING INVESTMENT, AND WE INVEST ONLY IN NEW AND EXPONENTIALLY GROWING INDUSTRIES, WHICH HAVE THE CAPABILITY TO RADICALLY CHANGE AND POSITIVELY INFLUENCE THE DEVELOPMENT OF MANKIND

The Fund s Areas of Specialization We predict that the greatest financial booms in the next five years will be in the following areas, and invest primarily in: BIOTECHNOLOGY with an emphasis on personalized medicine (preventive medicine, anti-aging, and reversal of aging) AEROSPACE as a realistic possibility for commercial space exploration and the expansion of human potential A hybrid of BIG DATA and AI especially in the field of personalized medicine, financial analysis and risk analysis In most cases, the projects in which we invest are high tech platforms In some cases, we are also interested in other projects related to exponential technologies

CyberFuture CyberFuture is our flagship company specialized on Artificial Intelligence & BigData VITAL (Validating Investment Tool for Advancing Life Sciences) SPOCK (Space Program Ontologically Computed Knowledge) Deals with forecasting and investment analysis in the biotechnology industry. We were the first fund to appoint the VITAL robot to the investment committee and give it an equal voice with human board members Thanks to the success of the VITAL project, we decided to support the CyberFuture team in adapting this system for other high potential and complex sectors while at the same time beginning to develop SPOCK. It developed as a machine learning program capable of producing real-time analysis of the global space ecosystem, which it will use to make intelligent investment recommendations. The data that SPOCK develops will feed into a new dynamic roadmap of space exploration

Deep Knowledge Ventures is Unique We know what companies, ideas, startups and projects are likely to fail in the near future, despite all their innovations, aggressive PR and strong branding, and even despite initial exponential growth. But more importantly, we can identify the 1% with a bright future Our robotic analytical systems: collect huge amounts of information extract useful and reliable data from this information it s allowing us to make the best decisions

AntiAging & Personalized Medicine Now anti-aging and personalized medicine is our highest priority for investment. It s thanks to VITAL that our first and most important investments are Pathway Pharmaceuticals and Insilico Medicine

Pathway Pharmaceuticals Pathway Pharmaceuticals with its first product, OncoFinder, made serious progress in the field of personalized anti-cancer therapy based on a unique algorithm for gene expression analysis

Insilico Medicine Inc. Insilico Medicine Inc. with its product, GeroScope, has demonstrated truly stunning results in the field of drug repurposing and age-related diseases, as well as encouraging results in the complex battle against aging. Insilico Medicine researchers have collected an unparalleled database of patterns of normal and pathological human tissue. This enables the ultra-efficient search for new drugs and the repurposing of existing drugs in the interest of Big Pharma companies

Hyper Web This is a company engaged in the development and implementation of advanced smart IT-platforms and mobile applications. Many of its unique designs have been used successfully in DKV portfolio companies the first being BeSmart, a system for managing and administering complex distributed projects

Incubator and Accelerator of Deep Knowledge Ventures DKV is a business incubator and accelerator for all of its portfolio companies and projects, creating an effective, integrated ecosystem in which they receive multi-faceted support and derive significant synergies. DKV promotes development and reduces their costs by promoting them in the media and providing support in networking, business development, HR and more. Startups are given unique access to DKV resources, including developments and service solutions created in other parts of the consortium. Our experts in the fields of strategic planning, business scaling, crisis management, innovative design and recruiting actively help companies both during the initial startup and at the beginning stages of exponential growth

Social responsibility and collaboration with nonprofit think tanks The world is developing exponentially and even as positive possibilities affecting the development of mankind open up, so do exponential risks. There is a clear lack of those who are able to look at the exponentially developing and complex world, take into account all the risks, conduct an analysis and project what the world will be like in 10-15 years. That s why we decided to support the creation of the Exponential Technology Institute that will study the development trends of exponential technologies, as well as study the opportunities and risks that these technologies entail in order to mitigate those risks and model positive development for the future. We also support Biogerontology Research Foundation in the UK, which is one of the main Think tanks in the world and fullfils effective networking and collaboration between specialists and scientists in the field of antiaging.

Our mission Positively impact human development by developing new industries Extend healthy human life by several decades (to 120 years or more) Identify and mitigate the risks facing humanity

Our business goal To generate significant returns and become the number one innovation venture fund in the world with a market capitalization of at least $ 10 billion in the coming years

Contacts INVESTMENT IN DISRUPTIVE INVESTMENT IN DISRUPTIVE EXPONENTIAL TECHNOLOGIES EXPONENTIAL TECHNOLOGIES Dmitry Kaminskiy Dmitry Kaminskiy Senior Partner Deep Knowledge Ventures Senior Partner deepknowledgeventures.com.com dk@deepknowledgeventures.com + 852 5801-44-06 ures.com + 44 (0) 2037-693-282 + 852 5801-44-06 + 44 (0) 2037-693-282 info@deepknowledgeventures.com 2702-3, Bank Of East Asia Harbour View Centre, 56 Gloucester Rd, Wan Chai, Hong Kong deepknowledgeventures.com r View Centre, 56 Gloucester Rd, Wan Chai, Hong Kong 2702-3, Bank Of East Asia Harbour View Centre, 56 Gloucester Rd, Wan Chai, Hong Kong